Company: TLSA
Filing Date: 2025-01-31
Form Type: 6-K
Source: 0001213900-25-008957
Chunk: 0

Company: Tiziana Life Sciences Ltd
Filing Date: 2025-01-31
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

January 2025

Commission File Number: 001-38723

Tiziana Life Sciences LTD

(Exact Name of Registrant as Specified in Its Charter)

9 thFloor

107 Cheapside

London

EC2V 6DN

(Address of registrant’s principal executive
office)</div>

Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.

<div align='center'>Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K</div>

On January 29, 2025, Tiziana Life Sciences LTD (the “”)
received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not currently
in compliance with the $1.00 Minimum Bid Price Requirement for continued listing of the Company’s common shares on the Nasdaq Capital
Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Notice indicated that, consistent
with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 days, or until July 28, 2025 (the “Compliance Deadline”), to regain
compliance with the Minimum Bid Price Requirement by having the closing bid price of the Company’s ordinary share’s meet or
exceed $1.00 per ordinary share for at least ten consecutive business days.

The Notice is only a notification of deficiency, not of imminent delisting,
and has no current effect on the listing or trading of the Company's securities on the Nasdaq Capital Market. Tiziana intends to monitor
the closing bid price of its common shares and may, if appropriate, consider implementing available options to regain compliance with
the Minimum Bid Price Requirement. If the Company does not regain compliance by the Compliance Deadline, the Company may be afforded an
additional 180 calendar day period to regain compliance.

The Company intends to resolve the deficiency and regain compliance
with the Listing Rules.

<div align='center'>1

SIGNATURES